Petros Pharmaceuticals (PTPI) News Mentions Statistics 2024

00%

1W 0% 1M 0%

Est. daily news mentions.

Similar companies

Company		News Mentions
	Amgen AMGN	0 100%
	Gilead Sciences GILD	1 0%
	Catalyst Pharmaceuticals CPRX	0 0%
	Inovio Pharmaceuticals INO	0 0%
	Anavex Life Sciences AVXL	0 0%

Critical Review: Petros Pharmaceuticals (NASDAQ:PTPI) and Protagonist Therapeutics (NASDAQ:PTGX)

October 28

Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)

September 10

12 Health Care Stocks Moving In Friday's Intraday Session

October 24

12 Health Care Stocks Moving In Wednesday's After-Market Session

October 22

12 Health Care Stocks Moving In Tuesday's After-Market Session

October 14

Petros executes initial test for app comprehension for STENDRA FDA pathway

September 10

How often is Petros Pharmaceuticals mentioned in the news?

Petros Pharmaceuticals was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Petros Pharmaceuticals performing compared to its industry peers?

Petros Pharmaceuticals underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Petros Pharmaceuticals in the last month?

There has been no significant change in the number of news mentions for Petros Pharmaceuticals' compared to the last month.

Why is it important to track news mentions for Petros Pharmaceuticals?

By monitoring mentions in the news for Petros Pharmaceuticals, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Petros Pharmaceuticals, ultimately improving their investment strategies.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

Top Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Petros Pharmaceuticals (PTPI) - News Mentions

Similar companies

Amgen

Gilead Sciences

Catalyst Pharmaceuticals

Inovio Pharmaceuticals

Anavex Life Sciences